The Modified Simple Screening Instrument for Substance Abuse (MSSI-SA) can be used to screen for alcohol and drug dependence, including prescription and over-the-counter medicines. You can view the screening tool below.
These videos support providers to enhance their understanding of how stigma impacts healthcare for people with opioid use disorder and include strategies for best practices to reduce stigma and improve health outcomes for patients.
In 2017, there were 1,487 unintentional drug overdose deaths in New York City. Learn what you can do to prevent overdoses.
Find participating pharmacies by searching the NYC Health Map.
The NYC Department of Health has guidance for how providers at NYC emergency departments should care for patients following a non-fatal overdose.
Opioid use disorder (addiction) is a treatable health condition. Learn more about treating opioid use disorder.
The Health Department's Buprenorphine Training and Technical Assistance Initiative provides free buprenorphine waiver training and technical assistance for physicians, nurse practitioners, and physician assistants practicing in NYC. Buprenorphine is an effective medication for treatment of opioid use disorders, and it can be prescribed in office-based primary care settings.
Physicians are required to complete an eight-hour training in order to apply for a waiver; nurse practitioners and physician assistants must take 24 hours of training (inclusive of the eight-hour training) in order to apply. This course fulfills the eight-hour training requirement. The half-and-half format will include approximately four hours of online training due prior to approximately four hours of in-person training. For more information, including dates of upcoming trainings, email firstname.lastname@example.org.
This e-learning series offers local health departments and community partners guidance and resources on evidence-informed public health responses to the opioid crisis using a harm reduction approach.